Benzalkonium Chloride (BZK) is a quaternary ammonium compound widely used as an antiseptic, disinfectant, and preservative in healthcare, household, and personal care products. It works by disrupting microbial cell membranes, causing leakage of cellular contents and death of bacteria, fungi, and certain viruses. BZK is valued for its broad antimicrobial activity, stability, and compatibility with formulations where alcohol-based agents are unsuitable. This guide explores its uses, dosage, side effects, interactions, and benefits to help you understand its versatility and applications.
Benralizumab is a monoclonal antibody (mAb) that selectively targets the interleukin-5 receptor alpha (IL-5R?) on eosinophils and basophils. It is approved for the management of severe eosinophilic asthma in adults and adolescents aged 12 years and older. By inducing near-complete depletion of eosinophils, Benralizumab helps control airway inflammation, reduce exacerbations, and improve overall asthma control. It is marketed under the brand name Fasenra? by AstraZeneca.
Bendamustine is an alkylating antineoplastic agent used in the treatment of hematologic malignancies such as chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). It works by causing crosslinking of DNA strands, thereby preventing cancer cell division and triggering apoptosis (cell death). Approved by the U.S. FDA, Bendamustine is indicated as a frontline or second-line therapy for CLL and indolent B-cell NHL that has progressed after prior treatments.
Benazepril is an oral angiotensin-converting enzyme (ACE) inhibitor used to manage hypertension, heart failure, and chronic kidney disease (CKD). It helps relax blood vessels and reduce the workload on the heart by blocking the conversion of angiotensin I to angiotensin II - a potent vasoconstrictor. Approved by the U.S. FDA, Benazepril is prescribed alone or in combination with other antihypertensives to lower blood pressure, prevent cardiovascular events, and protect kidney function.
Bempedoic Acid is a first-in-class oral lipid-lowering medication used to reduce low-density lipoprotein cholesterol (LDL-C) levels in adults with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH). It works by inhibiting ATP-citrate lyase (ACL), an enzyme involved in hepatic cholesterol synthesis.
Belinostat is an intravenous histone deacetylase (HDAC) inhibitor used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). It works by inhibiting histone deacetylase enzymes, which regulate gene expression, thereby promoting cell cycle arrest and apoptosis in malignant cells.
Belimumab is a biologic immunosuppressive medication used to treat autoimmune diseases such as systemic lupus erythematosus (SLE) and lupus nephritis. It is a fully human monoclonal antibody that inhibits the activity of the B-lymphocyte stimulator (BLyS), also known as B-cell activating factor (BAFF). By blocking this protein, Belimumab reduces the survival of autoantibody-producing B-cells, helping to control immune overactivity and inflammation. Approved by the U.S. FDA in 2011, it is the first biologic therapy specifically developed for lupus.
Belatacept is a selective T-cell co-stimulation blocker used as an immunosuppressive therapy in kidney transplant recipients. It prevents organ rejection by inhibiting T-cell activation, thereby suppressing the immune response against the transplanted organ. Approved by the U.S. FDA in 2011, Belatacept provides an alternative to traditional calcineurin inhibitors (CNIs) such as cyclosporine and tacrolimus, offering comparable efficacy with reduced nephrotoxicity and improved long-term graft survival.
Bedaquiline is an oral diarylquinoline antibiotic used in the treatment of multidrug-resistant tuberculosis (MDR-TB) and certain cases of extensively drug-resistant tuberculosis (XDR-TB). It works by inhibiting mycobacterial ATP synthase, an enzyme essential for the energy production and survival of Mycobacterium tuberculosis. Approved by the U.S. FDA in 2012, it is a crucial addition to combination regimens for resistant TB, especially where standard first-line drugs like isoniazid and rifampicin are ineffective.
Beclomethasone is a synthetic corticosteroid used for its anti-inflammatory and immunosuppressive effects in managing respiratory diseases (particularly asthma and COPD), allergic rhinitis, dermatological disorders like eczema/psoriasis, and ulcerative colitis. Multiple formulations are available, including inhalers, nasal sprays, topical creams, and oral/rectal tablets. This guide provides a comprehensive overview of Beclomethasone, including its uses, dosage, side effects, and more.
